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  Infection after fracture fixation is a feared complication in 
orthopaedic surgery leading to poor bone healing and 
loss of function.
  Early detection is essential and interdisciplinary care is 
mandatory.
  Eradication of infection is only possible through combined 
surgical and antibiotic treatment.
  Intraoperative tissue samples must be taken and are effec-
tive for guidance of the antibiotic regimen.
  Infection after fracture fixation is different from prosthetic 
joint infection (PJI) and needs a specific strategy.
  In this review, we define infection after fracture fixation, 
and outline the clinical, radiological and laboratory signs 
of these infections, as well as a treatment algorithm for 
optimal patient care.
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Introduction
Infection after fracture fixation (IAFF) in orthopaedic sur-
gery is a dreaded complication, leading to non-union, loss 
of function, and even amputation. It is not only a source of 
morbidity and mortality,1 but it also brings an important 
socio-economic burden.2 The success rate in the treatment 
of IAFF is between 70% and 90%.3 Some studies report an 
incidence of IAFF for closed fractures of 1% to 2% with an 
incidence even reaching up to 30% in open fractures.4 
However, the real incidence of IAFF is probably underesti-
mated due to a lack of precise definition. When looking at 
the current literature, many studies have concentrated on 
prosthetic infections. Most of the applied concepts in the 
treatment of IAFF are adaptations of algorithms found in 
prosthetic infections management. It is important to notice 
that those two identities must be distinguished. While the 
ultimate goal in the treatment of infected total joint is the 
eradication of the infection and a sterile implant, the goal 
of the treatment of an IAFF is the healing of the fracture and 
the avoiding of chronic osteomyelitis. Furthermore, after 
consolidation of the bone, the implant can be extricated, 
contrary to the prosthesis. This allows for a more permis-
sive attitude, with use of suppressive antibiotics until 
retrieval of the implant. Diagnostics in IAFF can be compli-
cated because identification of the germ is often only pos-
sible after intraoperative sampling, in contrast to prosthetic 
infections where joint aspiration can help preoperatively 
with diagnostics and establishment of a treatment plan.
Compared to patients presenting for elective surgery, 
traumatic patients have generally more soft tissue dam-
age, with even direct contamination in case of open frac-
tures. Those delicate cases often need multiple surgeries 
going from delayed definitive fixation to cutaneous cover-
age by plastic surgeons. The infection rate between a 
patient scheduled for elective surgery and the fracture 
patient is thus not equivalent. On the other hand, 
mechanic stability is required in order to prevent infection 
and gain definitive bone healing.5,6
Definition
For a long time, no international definition of IAFF existed. 
Patient care was inspired by algorithms in prosthetic infec-
tion care. But after questioning of those algorithms by 
some surgeons, it became apparent that neither the 
guidelines of the CDC (Centers for Disease Control and 
Prevention), nor the guidelines of the prosthetic infections 
were optimal in patient care of IAFF. With the support of 
the Arbeitsgemeinschaft für Osteosynthesefragen (AO) 
Foundation, an international consensus has finally been 
found in 2018 fixing an organigram helping in decision 
taking in fracture-related infections (FRI) (Table 1).7
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Classification
Even with a clear definition in mind, there are still a lot of 
different classifications available for IAFF. Willenegger and 
Roth classify IAFF simply according to time, following 
onset of patient symptoms, into three groups: early (less 
than 2 weeks), delayed (2–10 weeks), and late onset 
(more than 10 weeks) infection:8
 • Early IAFFs present with classic signs of infection (rubor, 
calor, dolor, tumor and functio laesa), wound healing 
disturbances and systemic signs of infection such as 
fever. Within this period, it is considered that the causa-
tive bacteria may already have formed a biofilm, 
although this biofilm may still be in an ‘immature’ 
phase. Highly virulent organisms, like Staphylococcus 
aureus or gram-negative bacilli, are frequent causative 
agents of early infection.4
 • Delayed infections are typically due to less virulent 
bacteria, such as Staphylococcus epidermidis or Cuti-
bacterium acnes.4 In this situation the biofilm is mature 
and more resistant to antibiotic therapy. Patients with 
delayed infections can present with symptoms con-
sistent with either early or late infections.
 • Late infections are primarily caused by microorgan-
isms of low virulence like Staphylococcus epider-
midis.4 The compromised fracture healing is a frequent 
observation in late infections, as is osteomyelitis with 
sequestrum or involucrum.
Diagnosis
Clinical
Clinical diagnosis can now be made more easily, with the 
consensus definition in mind. One can use the confirma-
tory criteria such as fistula, sinus, wound breakdown, puru-
lent drainage. new onset or excessive pain, local redness, 
local swelling, increased local temperature or fever are sug-
gestive criteria.7 Fever is an interesting criterion with a sen-
sitivity of 89%, specificity of 57%, positive predictive values 
of 28% and negative predictive values of 96%.9
Laboratory examination
When doubt subsists on clinical assessment, even though 
some suggestive criteria are present, laboratory examina-
tion is helpful as a new suggestive criterion and also helps 
us monitor treatment efficiency. This includes leukocytes 
count and C-Reactive Protein (CRP) dosage. new markers, 
such as Interleukine-6, combined with the CRP seem to be 
interesting in detecting low grade infection,7 but they are 
not to be used in primary intention.
Radiology
It is well known that x-rays have a low sensibility and 
specificity in diagnosing IAFF (soft tissue tumefaction, per-
iosteal reaction), but it remains the first step in the bone 
assessment and for excluding other causes such as mal-
reduction, malposition of the internal fixation or loss of 
Table 1. Definition of infection after fracture-related infection, as proposed by Metsemakers et al.7
Confirmatory criteria  
Fistula, sinus or wound breakdown (probe to bone or implant).
 Purulent drainage from the wound or presence of pus during surgery.
 Phenotypically indistinguishable pathogens identified by culture from at least two separate deep tissue/implant (including 
sonication-fluid) specimens taken during an operative intervention. In case of tissues, multiple specimens should be taken, each 
with clean instruments (not superficial). In case of joint effusion near the fracture site, sterile puncture may be included as a 
single sample.3
 Presence of pathogens in deep tissue, taken during an operative intervention, as confirmed by histopathological examination 
using specific staining techniques for bacteria or fungi.
Suggestive criteria
Clinical signs Any of:
- Pain, typically without weight bearing, increasing over time, new onset
- Local redness
- Local swelling
- Increased local temperature
- Fever (single oral temperature measurement of 38.3°C)
-  Persistent, increasing or new-onset wound drainage, beyond the first few days postoperatively, without solid alternative 
explanation
-  new onset of joint effusion in fracture patients. Infection after fracture fixation (IAFF) can present as an adjacent septic arthritis 
in: implant material which penetrates the joint capsule (e.g. femoral nailing), intra-articular fractures
Radiological signs Any of:
- Bone lysis (fracture site, around the implant)
- Implant loosening
- Sequestration
- non-union
- Periosteal bone formation, at localizations other than the fracture site
Microbiologic sign A pathogenic organism identified by culture from a single deep tissue/implant specimen taken during an operative intervention.
Laboratory signs Elevated serum inflammatory markers: especially suggestive in a case of secondary rise (after an initial decrease), or a consistent 
elevation over a period of time (erythrocyte sedimentation rate, white blood cell count, C-reactive protein).
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reduction. It also gives an indication on the bone healing 
process, which is a criterion in the patient care.
CT-scan is more precise when there is a suspicion of 
chronic IAFF in searching for sequesters, involucrum or 
clear periosteal reaction. The presence of air is also an 
important sign at a distance from the surgery, as it can still 
be present in direct postoperative imagery. As for stand-
ard x-rays, the CT-scan brings information of the bone 
healing process.10
MRI can detect osseous or soft tissue oedema, but 
those parameters are also present in the days or weeks 
after surgery, rendering those signs mainly useful at a dis-
tance from the surgery. Due to metallic artefacts of the 
internal fixation, visualization of nearby structures can be 
problematic. nowadays, specific techniques can reduce 
those artefacts.11,12
nuclear medicine is also a diagnostic tool with scintigra-
phy, associated or not with a CT-scan. This remains a good 
solution for detecting infected sites at distance. The princi-
pal advantages are early detection after infection has 
started and a good sensibility;11 disadvantages are its low 
specificity and its residual contract uptake until one to two 
years after initial trauma.
Microbiological
A pathogenic microorganism grown in culture from a sin-
gle deep tissue sample or implant (including sonication-
fluid) taken during an operative intervention is a subjective 
criterion.7 In case of tissue sampling, multiple specimens 
(> 3) should be taken, each with clean instruments (no 
superficial tissue or sinus tract swabs). 13 In cases of 
joint effusion arising in a joint adjacent to a fractured 
bone, a fluid sample obtained by sterile puncture is 
helpful.7
Sonication has the advantage of loosening bacteria 
off the surface of the implant and stimulating them back 
into a planktonic state making them available for cultur-
ing. A part of the internal fixation device, for example, a 
single screw, can be sent for sonication. The removed 
screw can be replaced by a new screw. These methods 
increase the percentage of positive cultures, in particu-
lar in patients for whom antibiotic treatment has already 
been initiated.14 Culture duration is generally between 5 
and 14 days in order to balance the risk for missing a 
pathogen with difficult or slow growth from a simple 
contaminant. Another advantage of the culture is that 
an antibiogram can be completed. In case of doubt or in 
presence of contradictory results, polymerase chain 
reaction (PCR) analysis permits an identification of bac-
teria difficult to cultivate or bacteria in patients where 
antibiotics were initiated,15 but without giving an indi-
cation of the proliferative state of the bacteria, nor of the 
antibiogram (Figure 1).16
Treatment
Important points for treatment
 • Eliminate other causes giving a possible similar picture 
as infection, namely hypersensitivity to fracture fixa-
tion devices.17
 • Goals are treating the infection, healing the fracture, 
preserving soft tissues and obtaining optimal restitu-
tion of the function.
 • Definitive and immediate treatment of the infection is 
not always the priority. Bone healing can be the pri-
mary objective, as the internal fixation device can be 
retrieved once consolidation is obtained. Suppressive 
treatment has thus a place in the treatment. 18
 • After suppressive treatment, the material must be 
retrieved in order to avoid risk of recrudescence of 
infection or chronic osteomyelitis.19
Surgical aspect
The first question is: ‘did the fracture consolidate’? If the 
fracture has healed, treatment would be a debridement 
and complete retrieval of the internal fixation device, fol-
lowed by two weeks of intravenous antibiotics, and four 
weeks of oral antibiotics to prevent osteomyelitis. The 
debridement must be done carefully and include the com-
plete removal of necrotic/infected tissues and dead bone. 
It must be renewed if necessary and if possible by the 
same surgical team.
If the fracture has not healed completely, timing of ini-
tial infection onset is important. The biofilm appears after 
a few hours,20 but this does not seem to always prevent 
the fracture callus from forming in an infectious con-
text.21,24 In case of early infection (< 2 weeks), the follow-
ing questions are:
 • Is the implant stable?
 • Is the reduction acceptable?
 • Is skin closure possible?
If the criterion of acceptable reduction is fulfilled and 
the implant is stable with a safe cutaneous situation, an 
acceptable solution can be debridement with retention of 
the implants followed by 12 weeks of antibiotics, of which 
the first two weeks should be administered intravenously. 
If the implant is unstable with a poor reduction and soft 
tissues closure is not possible, the surgical option of mate-
rial retrieval, temporary fixation (internal or external) with 
six weeks of antibiotic treatment (two weeks IV + two 
weeks per os (p.o.)) is an option, followed by new internal 
fixation at six weeks together with antibiotics (one week IV 
+ five weeks p.o.) (Figure 2).
In case of late infection, the treatment goal can be eradi-
cation or suppression of the infection. It would be preferable 
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IAFF evaluation
Multidisciplinary diagnostic algorithm for infection after fracture fixation (IAFF) 
Medical history
Laboratory tests Imaging
IAFF TREATMENT 
IAFF treatment considerations
MULTIDISCIPLINARY PLANNING AND REEVALUATION
Infectious diseases Orthopaedic surgery Plastic surgery
- Local or systemic infection? 
- Chronology / classification: onset of symptoms after fixation: early / delayed / late
- Fracture: 
 - method of fixation: plate, intramedullary nailing, external fixation
 - stability of implant, quality of reduction, fracture consolidation with or without callus
   formation, sequestration
 - Localization: extra-/intra-articular, meta-/diaphyseal, intra-/extra-medullar
 - Soft-tissue state: debridement possible, need for a flap
- Pathogens: 
 - previous infection at site of fracture?
 - difficult to treat pathogens?
- complete blood count
- inflammatory parameters
 (CRP, WBC)
- coagulation parameters and
 blood group in prevision of
 surgery
- liver and renal parameters
 for antimicrobial therapy
1. Plain radiography:
 search for bone lysis,
 sequestration, non-union,
 implant loosening,
 periosteal bone formation.
2. CT, MRI, nuclear imaging
Analysis of synovial
 fluid:
- cell count
- cell differentiation
 and neutrophils %
- bacterial culture
- new adjacent joint effusion
- fistula / wound breakdown
- purulent discharge
- local / systemic signs of infection
Trauma: low/high energy,
 mono-/polytrauma,
 fracture type, soft tissue, vascular or
 nerve injuries, need for a flap coverage
Host: diseases, allergies, medications,
 previous antibiotic treatments, results
 from microbiology, wound healing
 disorders
- gram staining, cultures
 of intraoperative
 samples, sonication of
 removed implant
- determine antibiotic
 treatment regime,
 according to pathogens 
- antibiotic treatment
 surveillance, specially
 renal and hepatic
 function 
Adequate sampling:
- at least 3 deep tissuse /
 bone samples from the
 site of infection 
- each sample with a new
 clean instrument 
- sample in a sterile
 transport container 
- removed implant has to
 be sent to sonication
- debridement
- evaluation of fracture
 stability 
- +/- implant removal
- primary wound closure 
- need for a flap
Joint puncture
Clinical presentation
Fig. 1 Multidisciplinary diagnostic algorithm for infection after fracture fixation (IAFF), suggested by Metsemakers et al.7
to choose the option of eradication with difficult-to-treat 
germs (DTT) and if soft tissue quality is poor. If one of 
those two criteria is present, it is advised to make an 
exchange in two stages with debridement, six weeks of 
antibiotics (two weeks IV + four weeks p.o.) with external 
or internal fixation, followed by a re-osteosynthesis and 
antibiotics (one week IV + five weeks p.o.). If none of these 
criteria are present, a one-stage exchange with 12 weeks 
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of antibiotics should be the preferred treatment. The 
choice of suppressive therapy implies debridement, fol-
lowed by two weeks of antibiotics IV, followed by a long 
course of oral antibiotics until final retrieval of the internal 
fixation device (Figure 2).
From a surgical perspective, the treatment of a late 
infection must be planned thoroughly using imagery 
searching for sequesters and dead bone. Intraoperatively, 
the surgeon must evaluate bony bleeding in order to 
know its vitality. An important resection can give a signifi-
cant loss of stability and necessitate more complicated 
reconstruction methods such as the Masquelet induced-
membrane technique or bone transport.
Antibiotic therapy
The antibiotic therapy must be systematically intrave-
nous in the first instance, then adapted in function of the 
treatment option (suppressive or curative), the pathogen 
and the localization (osteitis, osteomyelitis or arthritis). 
Tables 2 and 3 can serve as red line in antibiotic therapy, 
but must be discussed with the infectious disease 
specialist.
YES Is the fracture healed?
Early infection
< 2 weeks
1. Implant stable?
2. Good reduction of
 fracture?
3. Primary skin closure
 possible?
1. Bad soft tissue?
2. Difficult-to-treat infection:
- Rifampicin-resistant staphylococci
- Ciprofloxacin-resistant
 gram-negative bacteria
- fungi (Candida) 
NO
Late infection
> 10 weeks
Eradication Suppression
Debridement
+
Removal of
implant
Debridement
+
Implant retention
Antibiotics
12 weeks OR
suppressive
therapy until 
fracture healing
1st step: removal of
implant and temporary
stabilization
Antibiotics
6 weeks
2nd step:
re-osteosynthesis
Antibiotics
6 weeks
Antibiotics
12 weeks
One-stage
exchange
Two-stage
exchange
Debridement
Antibiotics long
term until
removal of implant
Antibiotics
6 weeks
YESYES NO NO
Fig. 2 Treatment algorithm for infection after fracture fixation.
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Table 2. Antibiotic therapy table for infection after fracture infection suggested antibiotic eradication therapy according to microorganism
Microorganism Antibiotic therapy Dose
(normal renal function)
Route
Staphylococcus spp.
Methicillin-susceptible 2 weeks:
 - Flucloxacillin
Followed by (according to susceptibility):
Rifampicin +
 - Levofloxacin or
 - Cotrimoxazole or
 - Doxycyclin or
2 g, every 6 h
450 mg, every 12 h
500 mg, every 12 h
960 mg, every 8 h
100 mg, every 12 h
IV
p.o.
p.o.
p.o.
p.o.
Methicillin-resistant 2 weeks:
 - Vancomycin or
 - Daptomycin or
 - Fosfomycin
Followed by an oral rifampicin combination as above
15 mg/kg, every 12 h
6–8 mg/kg, every 24 h
5 g, every 8h
IV
IV
IV
Rifampicin-resistant IV treatment according to susceptibility for 2 weeks (as above), followed by long-term suppression for > 1 year
Streptococcus spp. 2–4 weeks:
 - Penicillin G or
 - Ceftriaxone
Followed by:
 - Amoxicillin or
 - Levofloxacin
5 Mio Iu, every 6 h
2 g, every 24 h
1000 mg, every 8 h
500 mg, every 12 h
IV
IV
p.o.
p.o.
Enterococcus spp.
Penicillin-susceptible 2–3 weeks:
 - Ampicillin +
 - Gentamicin +/-
 - Fosfomycin
Followed by:
- Amoxicillin
2 g, every 6 h
120 mg, every 24 h
5 g, every 8 h
1000 mg, every 8 h
IV
IV
IV
p.o.
Penicillin-resistant 2–4 weeks:
 - Vancomycin or
 - Daptomycin
+
 - Gentamicin or
 - Fosfomycin
Followed by:
 - Linezolid
2 g, every 6 h
10 mg/kg, every 24 h
120 mg, every 24 h
5 g, every 8 h
600 mg, every 12 h
IV
IV
IV
IV
p.o.
Vancomycin resistant (VRE) Individual. Removal of the implant or suppression until implant removal
Gram-negative
Enterobacteriaceae (E. coli, Klebsiella, 
Enterobacter etc.)
- Ciprofloxacin 750 mg, every 12 h p.o.
nonfermenteres (Pseudomonas aeruginosa, 
Acinetobacter spp.)
2–3 weeks:
 - Piperacillin/tazobactam or
 - Meropenem or
 - Ceftazidim
+
 - Tobramycin or
 - Gentamicin or
 - Fosfomycin
Followed by:
 - Ciprofloxacin
4.5 g, every 8 h
1 g, every 8 h
2 g, every 8 h
300 mg, every 24 h
240 mg, every 24 h
5 g, every 8 h
750 mg, every 12 h
IV
IV
IV
IV
IV
IV
p.o.
Ciprofloxacin-resistant Depending on susceptibility (IV, alone or in combination):
 - Meropenem 2 g, every 8 h
 - Colisitin 3 Mio Iu every 8 h
 - Fosfomycin 5 g, every 8 h
Anaerobes  
Gram-positive (Propionibacterium, 
Peptostreptococcus, Finegoldia magna)
2 weeks:
 - Penicillin G or
 - Ceftriaxone
Followed by:
 - Rifampicin +
 - (Levofloxacin or
 - Amoxicillin)
5 Mio Iu, every 6 h
2 g, every 14 h
450 mg, every 12 h
500 mg, every 12 h
1000 mg, every 8 h
IV
IV
p.o.
p.o.
p.o.
Gram-negative (Bacteroides) 2 weeks:
 - Ampicillin/sulbactam or
 - Amoxicillin/clavulanic acid
Followed by:
 - Metronidazol
3 g, every 8 h
2.2 g, every 8 h
500 mg, every 8 h
IV
IV
p.o.
(Continued)
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When implants are retained, a curative treatment is 
generally only efficient if a biofilm-active antibiotic is 
administrated. until now, only rifampicin has shown to be 
efficient against staphylococci and quinolones against 
Gram-negative bacteria.20,23 Rifampicin must at all times 
be associated with a second antibiotic as there is a rapid 
resistance to it. For the same reason, Rifampicin must 
never be initiated in the very beginning of the antibiotic 
treatment, and if possible after removal of the drain and 
once the wound is dry.21
The use of local antibiotic allows for high bactericidal 
doses in loco. This is even more of interest in the case of 
bad local blood flow or in patients unable to receive sys-
temic antibiotics at usual dosage for various reasons.24,25 
In some cases, acute renal failure has been described after 
use of local antibiotics.26,27 Research on post-traumatic 
osteomyelitis treatment has evolved to local optimal 
administration of antibiotics via poly methyl methacrylate 
(PMMA) cement beads impregnated with antibiotics. It is 
known that not all antibiotics are released from the 
cement,22 and that Vancomycin and gentamicin have a 
synergistic effect when mixed together in PMMA 
cement.28 Absorbable materials, such as calcium sul-
phate, have the advantage of disposing of a broader 
range of antibiotics, but have the disadvantage of 
contributing to prolonged leakage of the wound.29 
Another advantage of local bone fillers, besides the bacte-
ricidal effect, is the management of dead space in the 
presence of cavities or bone defects. At present, local 
antibiotics have failed to prove their efficacy.30
Conclusion
In conclusion, IAFF is one of the most challenging com-
plications in orthopaedic trauma surgery. It implies 
severe consequences not only for patients but also for 
the health care system. nowadays, a clear definition, 
classification and treatment of IAFF based for a stepwise 
approach have been established. Awareness of this 
potential complication, early recognition of IAFF, inten-
sive debridement and a multidisciplinary approach are 
keys to a successful treatment.
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Microorganism Antibiotic therapy Dose
(normal renal function)
Route
Candida spp.
Fluconazole-susceptible 2 weeks:
 - Caspofungin
Followed by:
 - Fluconazole (suppression for > 1 year)
70 mg, every 24 h
400 mg, every 24 h
IV
p.o.
Fluconazole-resistant Individual (e.g. with voriconazole 200 mg, every 12 h, p.o.); removal of the implant or long-term suppression
Culture-negative 2 weeks:
 - Ampicillin/sulbactam or
 - Amoxicillin/clavulanic acid
Followed by:
 - Rifampicin +
 - levofloxacin
3 g, every 8 h
2.2 g, every 8 h
450 mg, every 12 h
500 mg, every 12 h
IV
IV
p.o.
p.o.
note. IV, intravenously; p.o., per os.
Source: www.pro-implant-foundation.org.
Table 2. (Continued)
Table 3. Antibiotic treatment according to pathogen for targeted eradica-
tion therapy
Microorganism Suppressive therapy
Staphylococcus spp. Cotrimoxazole or doxycycline or 
clindamycin
Streptococcus spp. Amoxicillin or clindamycin or 
levofloxacin
Enterococcus spp. Amoxicillin (or linezolid)
Anaerobes (gram-positive) Clindamycin or amoxicillin
Anaerobes (gram-negative) Metronidazole or clindamycin
Gram-negative organisms Ciprofloxacin or cotrimoxazole
Fungi (Candida spp.) Fluconazole
Source: www.pro-implant-foundation.org.
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